Biotech Archives

After Lilly-Kelonia deal, are any in vivo biotechs left to buy?

Suhas Bhokare2 months ago2 months ago08 mins

Eli Lilly’s $7 billion deal for Kelonia Therapeutics on Monday was simply the most recent instance of the sky-high costs that Big Pharmas are prepared to pay for in vivo CAR-T tech. In truth, it was the corporate’s second play for the area this 12 months—having bought Orna Therapeutics for up to $2.4 billion in February. Lilly…

Eli Lilly to buy Boston biotech Kelonia for .25 billion

Eli Lilly to buy Boston biotech Kelonia for $3.25 billion

Suhas Bhokare3 months ago3 months ago03 mins

Pharmaceutical powerhouse Eli Lilly & Co. will buy Boston gene remedy maker Kelonia Therapeutics for at the least $3.25 billion, the businesses introduced Monday. The acquisition will grant Indianapolis-based Lilly entry to Kelonia’s blood most cancers remedy referred to as KLN-1010 that genetically modifies sufferers’ immune cells with out requiring them to be faraway from…